InvestorsHub Logo
icon url

Bourbon_on_my_cornflakes

01/16/17 2:20 PM

#11245 RE: shub #11243

simple Shrub, Aduro was chosen to work on gastric cancer because they have developed a vaccines for gastric cancer, while ADXS has focused on other cancers such as prostate. but you knew that already, didnt you?
icon url

fbg0316

01/16/17 2:26 PM

#11246 RE: shub #11243

Look at page 6 on ADXS' corporate presentation. We don't have a construct targeting gastric cancer, while ADRO does. I view the collaboration with ADRO positive with respect to our combo trial with Merck on prostate (i.e., if our combo data is showing positive signs, it may have pushed Merck to also do a trial with ADRO on gastric cancer given the promise of listeria vaccines in combo regimens).
icon url

ignatiusrielly35

01/16/17 2:43 PM

#11248 RE: shub #11243

I wonder if ADRO will also try to infringe our NEO and HOT patents.